Vitamin D3 And Irritable Bowel Syndrome: Review
DOI:
https://doi.org/10.59680/ishel.v2i2.1161Keywords:
Vitamin, Irritable Bowel Syndrome, IBS, D3, calcifediolAbstract
Irritable bowel illness is a widespread health ailment that affects almost every age group around the world. The pathogenesis of IBS is still poorly understood. It is a prevalent dysfunctional bowel condition marked by recurring stomach pain or discomfort and changed bowel habits. A central concept is that IBS symptoms are caused by a bilateral imbalance of brain-gut connections, which appears as increased gut sensation and changed bowel patterns. The purpose of the review is to determine the role of vitamin D levels in people with irritable bowel syndrome patients. Vitamin D, which plays a role in inflammatory processes, can affect a variety of pathways implicated in the appearance of IBS. Vitamin D insufficiency was shown to be greater in the IBS group, indicating a relationship between vitamins.
References
Yang, W., Yang, X., Cai, X., Zhou, Z., Yao, H., Song, X., ... & Xiong, P. (2022). The prevalence of irritable bowel syndrome among Chinese university students: a systematic review and meta-analysis. Frontiers in Public Health, 10, 864721.?
Roisinblit KC. (2013) irritable bowel syndrome in women. J Midwifery Womens Health ,58:15–24; quiz 116.
Lacy, B. E., & Patel, N. K. (2017). Rome criteria and a diagnostic approach to irritable bowel syndrome. Journal of clinical medicine, 6(11), 99.?
Ford, A. C., Sperber, A. D., Corsetti, M., & Camilleri, M. (2020). Functional gastrointestinal disorders 2 irritable bowel syndrome. Lancet, 396(10263), 1675-1688.?
Ford, A.C.; Lacy, B.E.; Talley, N.J. (2017). Irritable Bowel Syndrome. N. Engl. J. Med., 376, 2566–2578.
Depression, W. H. O. (2017). Other common mental disorders: global health estimates. Geneva: World Health Organization, 24.?
Zamani, M., Alizadeh?Tabari, S., & Zamani, V. (2019). Systematic review with meta?analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome. Alimentary pharmacology & therapeutics, 50(2), 132-143.?
Liu, Q., He, H., Yang, J., Feng, X., Zhao, F., & Lyu, J. (2020). Changes in the global burden of depression from 1990 to 2017: Findings from the Global Burden of Disease study. Journal of psychiatric research, 126, 134-140.?
Santomauro, D. F., Herrera, A. M. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., ... & Ferrari, A. J. (2021). Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. The Lancet, 398(10312), 1700-1712.?
Black, C. J. & Ford, A. C. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat. Rev. Gastroenterol. Hepatol. 17, 473–486 (2020).
Meringer, H. & Mehandru, S. Gastrointestinal post-acute COVID-19 syndrome. Nat. Rev. Gastroenterol. Hepatol. 19, 345–346 (2022).
Staudacher, H. M., Black, C. J., Teasdale, S. B., Mikocka-Walus, A., & Keefer, L. (2023). Irritable bowel syndrome and mental health comorbidity—approach to multidisciplinary management. Nature Reviews Gastroenterology & Hepatology, 1-15.?
Coeffier M, Gloro R, Boukhettala N, Aziz M, Lecleire S, Vandaele N, Antonietti M, Savoye G, Bole-Feysot C, Dechelotte P, Reimund JM, Ducrotte P. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome. Am J Gastroenterol 105: 1181–1188, 2010.
Cremon C, Carini G, Wang B, Vasina V, Cogliandro RF, De Giorgio R, Stanghellini V, Grundy D, Tonini M, De Ponti F, Corinaldesi R, Barbara G. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. Am J Gastroenterol 106: 1290–1298, 2011.
Martinez C, Vicario M, Ramos L, Lobo B, Mosquera JL, Alonso C, Sanchez A, Guilarte M, Antolin M, de Torres I, Gonzalez-Castro AM, Pigrau M, Saperas E, Azpiroz F, Santos J. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations. Am J Gastroenterol 107: 736–746, 2012.
Vivinus-Nébot M, Dainese R, Anty R, Saint-Paul MC, Nano JL, Gonthier N, Marjoux S, Frin-Mathy G, Bernard G, Hebuterne X, Tran A, Theodorou V, Piche T. Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells. Am J Gastroenterol 107: 75–81, 2012.
Cenac N, Andrews CN, Holzhausen M, Chapman K, Cottrell G, Andrade-Gordon P, Steinhoff M, Barbara G, Beck P, Bunnett NW, Sharkey KA, Ferraz JG, Shaffer E, Vergnolle N. Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 117: 636–647, 2007
Klooker TK, Braak B, Koopman KE, Welting O, Wouters MM, van der Heide S, Schemann M, Bischoff SC, van den Wijngaard RM, Boeckxstaens GE. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut 59: 1213–1221, 2010.
Barbara G, Wang B, Stanghellini V, de Giorgio R, Cremon C, Di Nardo G, Trevisani M, Campi B, Geppetti P, Tonini M, Bunnett NW, Grundy D, Corinaldesi R. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 132: 26–37, 2007.
hman L, Isaksson S, Lindmark AC, Posserud I, Stotzer PO, Strid H, Sjovall H, Simren M. T-cell activation in patients with irritable bowel syndrome. Am J Gastroenterol 104: 1205–1212, 2009.
Santos J, Yang PC, Soderholm JD, Benjamin M, Perdue MH. Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat. Gut 48: 630–636, 2001.
Barreau F, Ferrier L, Fioramonti J, Bueno L. Neonatal maternal deprivation triggers long term alterations in colonic epithelial barrier and mucosal immunity in rats. Gut 53: 501–506, 2004.
Barreau F, Salvador-Cartier C, Houdeau E, Bueno L, Fioramonti J. Long-term alterations of colonic nerve-mast cell interactions induced by neonatal maternal deprivation in rats. Gut 57: 582–590, 2008.
Neunlist M, Toumi F, Oreschkova T, Denis M, Leborgne J, Laboisse CL, Galmiche JP, Jarry A. Human ENS regulates the intestinal epithelial barrier permeability and a tight junction-associated protein ZO-1 via VIPergic pathways. Am J Physiol Gastrointest Liver Physiol 285: G1028–G1036, 2003.
Vitamin, D. (2007). deficiency. Holick MF. N Engl J Med, 357, 266-281.?
Munns, C. F., Shaw, N., Kiely, M., Specker, B. L., Thacher, T. D., Ozono, K., ... & Högler, W. (2016). Global consensus recommendations on prevention and management of nutritional rickets. The Journal of Clinical Endocrinology & Metabolism, 101(2), 394-415.?
Liu, C., Lu, M., Xia, X., Wang, J., Wan, Y., He, L., & Li, M. (2015). Correlation of serum vitamin D level with type 1 diabetes mellitus in children: a meta-analysis. Nutricion hospitalaria, 32(4), 1591-1594.?
He, L. P., Song, Y. X., Zhu, T., Gu, W., & Liu, C. W. (2022). Progress in the relationship between vitamin D deficiency and the incidence of type 1 diabetes mellitus in children. Journal of Diabetes Research, 2022.?
Yao, Y., Zhu, L., He, L., Duan, Y., Liang, W., Nie, Z., ... & Fang, Y. (2015). A meta-analysis of the relationship between vitamin D deficiency and obesity. International journal of clinical and experimental medicine, 8(9), 14977.?
Holick, M. F. (Ed.). (2010). Vitamin D: physiology, molecular biology, and clinical applications. Springer Science & Business Media.?
Attar, S. M., & Siddiqui, A. M. (2013). Vitamin d deficiency in patients with systemic lupus erythematosus. Oman medical journal, 28(1), 42.?
Nwosu, B. U., Maranda, L., & Candela, N. (2017). Vitamin D status in pediatric irritable bowel syndrome. PLoS One, 12(2), e0172183.?
Cho, Y., Lee, Y., Choi, Y., & Jeong, S. (2018). Association of the vitamin D level and quality of school life in adolescents with irritable bowel syndrome. Journal of clinical medicine, 7(12), 500.?
Khayyat, Y., & Attar, S. (2015). Vitamin D deficiency in patients with irritable bowel syndrome: does it exist?. Oman medical journal, 30(2), 115.?
Chong, R. I. H., Yaow, C. Y. L., Loh, C. Y. L., Teoh, S. E., Masuda, Y., Ng, W. K., ... & Ng, Q. X. (2022). Vitamin D supplementation for irritable bowel syndrome: A systematic review and meta?analysis. Journal of Gastroenterology and Hepatology, 37(6), 993-1003.?
Turner, J. R. (2009). Intestinal mucosal barrier function in health and disease. Nature reviews immunology, 9(11), 799-809.?
Barbara, G., Barbaro, M. R., Fuschi, D., Palombo, M., Falangone, F., Cremon, C., ... & Stanghellini, V. (2021). Inflammatory and microbiota-related regulation of the intestinal epithelial barrier. Frontiers in nutrition, 8, 718356.?
Wellington, V. N. A., Sundaram, V. L., Singh, S., & Sundaram, U. (2021). Dietary supplementation with vitamin d, fish oil or resveratrol modulates the gut microbiome in inflammatory bowel disease. International Journal of Molecular Sciences, 23(1), 206.?
Tang, H. Y., Jiang, A. J., Wang, X. Y., Wang, H., Guan, Y. Y., Li, F., & Shen, G. M. (2021). Uncovering the pathophysiology of irritable bowel syndrome by exploring the gut-brain axis: a narrative review. Annals of Translational Medicine, 9(14).?
Zhang, Z., Yang, X., Jia, Y., Wen, Y., Cheng, S., Meng, P., ... & Zhang, F. (2021). Vitamin D and the risks of depression and anxiety: an observational analysis and genome-wide environment interaction study. Nutrients, 13(10), 3343.?
Patrick, R. P., & Ames, B. N. (2014). Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism. The FASEB Journal, 28(6), 2398-2413.?
Kong, J., Zhang, Z., Musch, M. W., Ning, G., Sun, J., Hart, J., ... & Li, Y. C. (2008). Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. American Journal of Physiology-Gastrointestinal and Liver Physiology, 294(1), G208-G216.?
Li, Y. C., Chen, Y., & Du, J. (2015). Critical roles of intestinal epithelial vitamin D receptor signaling in controlling gut mucosal inflammation. The Journal of steroid biochemistry and molecular biology, 148, 179-183.?
Zehnder, D., Bland, R., Williams, M. C., McNinch, R. W., Howie, A. J., Stewart, P. M., & Hewison, M. (2001). Extrarenal expression of 25-hydroxyvitamin D3-1?-hydroxylase. The Journal of Clinical Endocrinology & Metabolism, 86(2), 888-894.?
McCann, J. C., & Ames, B. N. (2008). Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction?. The FASEB Journal, 22(4), 982-1001.?
Tazzyman, S., Richards, N., Trueman, A. R., Evans, A. L., Grant, V. A., Garaiova, I., ... & Corfe, B. M. (2015). Vitamin D associates with improved quality of life in participants with irritable bowel syndrome: outcomes from a pilot trial. BMJ open gastroenterology, 2(1), e000052.?
El Amrousy, D., Hassan, S., El Ashry, H., Yousef, M., & Hodeib, H. (2018). Vitamin D supplementation in adolescents with irritable bowel syndrome: Is it useful? A randomized controlled trial. Saudi Journal of Gastroenterology, 24(2), 109-114.?
Sprake, E. F., Grant, V. A., & Corfe, B. M. (2012). Vitamin D3 as a novel treatment for irritable bowel syndrome: single case leads to critical analysis of patient-centred data. Case Reports, 2012, bcr-2012.?
Hlavaty, T., Krajcovicova, A., Koller, T., Toth, J., Nevidanska, M., Huorka, M., & Payer, J. (2014). Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases. World journal of gastroenterology: WJG, 20(42), 15787.?
Nicholson, I., Dalzell, A. M., & El-Matary, W. (2012). Vitamin D as a therapy for colitis: a systematic review. Journal of Crohn's and Colitis, 6(4), 405-411.?
Casseb, G. A., Kaster, M. P., & Rodrigues, A. L. S. (2019). Potential role of vitamin D for the management of depression and anxiety. CNS drugs, 33(7), 619-637.?
Black CJ, Thakur ER, Houghton LA, Quigley EMM, Moayyedi P, Ford AC. Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut. 2020;69:1441–51
Cann, P. A., Read, N. W., Holdsworth, C. D., & Barends, D. (1984). Role of loperamide and placebo in management of irritable bowel syndrome (IBS). Digestive diseases and sciences, 29, 239-247.?
Ford, A. C., Moayyedi, P., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., ... & Quigley, E. M. (2014). American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Official journal of the American College of Gastroenterology| ACG, 109, S2-S26.?
Bijkerk, C. J., De Wit, N. J., Muris, J. W. M., Whorwell, P. J., Knottnerus, J. A., & Hoes, A. W. (2009). Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. Bmj, 339.?
Ford, A. C., Talley, N. J., Spiegel, B. M., Foxx-Orenstein, A. E., Schiller, L., Quigley, E. M., & Moayyedi, P. (2008). Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. Bmj, 337.?
Engsbro, A. L., Simren, M., & Bytzer, P. (2012). Short?term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification. Alimentary pharmacology & therapeutics, 35(3), 350-359.?
Drossman, D. A., Morris, C. B., Hu, Y., Toner, B. B., Diamant, N., Leserman, J., ... & Bangdiwala, S. I. (2005). A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology, 128(3), 580-589.?
Lacy, B. E., & Patel, N. K. (2017). Rome criteria and a diagnostic approach to irritable bowel syndrome. Journal of clinical medicine, 6(11), 99.?
Camilleri, M., Shin, A., Busciglio, I., Carlson, P., Acosta, A., Bharucha, A. E., ... & Zinsmeister, A. R. (2014). Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterology & Motility, 26(12), 1677-1685.?
Cantorna, M. T., Snyder, L., Lin, Y. D., & Yang, L. (2015). Vitamin D and 1, 25 (OH) 2D regulation of T cells. Nutrients, 7(4), 3011-3021.?
Zhang, H., Wu, H., Liu, L., Li, H., Shih, D. Q., & Zhang, X. (2015). 1, 25?dihydroxyvitamin D3 regulates the development of chronic colitis by modulating both T helper (Th) 1 and Th17 activation. Apmis, 123(6), 490-501.?
Konya V, Czarnewski P, Forkel M, Rao A, Kokkinou E, Villablanca EJ, et al. Vitamin D downregulates the IL-23 receptor pathway in human mucosal group 3 innate lymphoid cells. J Allergy Clin Immunol. 2018; 141:279–92.
